Cargando…
Surgical Therapeutic Strategy for Non-small Cell Lung Cancer with Mediastinal Lymph Node Metastasis (N2)
BACKGROUND AND OBJECTIVE: Approximately 30% of patients who are diagnosed with non-small cell lung cancer (NSCLC) are classified as N2 on the basis of metastasis to the mediastinal lymph nodes. The effectiveness of surgery for these patients remains controversial. Although surgeries in recent years...
Autores principales: | MA, Qianli, LIU, Deruo, GUO, Yongqing, SHI, Bin, SONG, Zhiyi, TIAN, Yanchu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000432/ https://www.ncbi.nlm.nih.gov/pubmed/20677562 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.04.14 |
Ejemplares similares
-
Surgical techniques and results of the pulmonary artery reconstruction for patients with central non-small cell lung cancer
por: Ma, Qianli, et al.
Publicado: (2013) -
Tracheal Carinal Reconstruction and Bronchovasculoplasty in Central Type Bronchogenic Carcinoma
por: LIU, Deruo, et al.
Publicado: (2010) -
Risk factors for recurrence after complete resection of pathological stage N2 non-small cell lung cancer
por: Qiang, Guangliang, et al.
Publicado: (2015) -
Surgical mediastinal lymph node staging for non-small-cell lung carcinoma
por: Lozekoot, Pieter W. J., et al.
Publicado: (2021) -
Fibrobronchoscopic cryosurgery for secondary malignant tumors of the trachea and main bronchi
por: Ma, Qianli, et al.
Publicado: (2016)